Does clinical method mask significant VTE-related mortality and morbidity in malignant disease? Mini review.

Johnson, Miriam.; Maraveyas, Anthony.

doi:10.1038/sj.bjc.6605091

Authors

Professor Miriam Johnson Miriam.Johnson@hull.ac.uk

Anthony Maraveyas A.Maraveyas@hull.ac.uk

Abstract

After more than 150 years of a recognised link between cancer and vascular thromboembolic events (VTE), and despite a greatly improved understanding of its pathophysiology, epidemiology and treatment, the management of patients with cancer and VTE is still limited. Limitations can be related to the thromboembolism itself, the underlying cancer, or to the management process. There is significant literature that deals with the first two, but very little regarding the systems we use, or how the inadequacies in documentation, identification and classification of VTE affect the cancer patients themselves. This review aims to raise awareness of this neglected area and stimulate research that may lead to improvements in patient care. British Journal of Cancer (2009) 100, 1837-1841. doi: 10.1038/sj.bjc.6605091 www.bjcancer.com Published online 2 June 2009 (C) 2009 Cancer Research UK

Journal Article Type	Review
Publication Date	Jun 9, 2009
Journal	BRITISH JOURNAL OF CANCER
Print ISSN	0007-0920
Publisher	Cancer Research UK
Peer Reviewed	Peer Reviewed
Volume	100
Issue	12
Pages	1837 - 1841
Institution Citation	Johnson, M., & Maraveyas, A. (2009). Does clinical method mask significant VTE-related mortality and morbidity in malignant disease? Mini review. The British journal of cancer / Cancer Research Campaign, 100(12), 1837 - 1841. doi:10.1038/sj.bjc.6605091
DOI	https://doi.org/10.1038/sj.bjc.6605091